NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NYSE · Medical Devices · USD

Stryker Corporation (SYK) Stock Analysis

Stryker Corporation (SYK) is a Medical Devices stock listed on NYSE and quoted in US Dollar.

Last Updated: October 21, 2026

SYK

$297.60

−$6.80 (−2.23%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare SYK with… →

SYK Key Statistics

As of Oct 21, 2026
Trading
Open
$297.57
Previous Close
$304.40
Day's Range
293.10–303.66
52-Week Range
267.00–392.55
Volume
2.41M
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.78
Valuation
Market Cap
$114.15B
P/E Ratio
30.84
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
17.86
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
1.42
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
4.42
EPS (ttm)Profit attributable to each share over the last twelve months.
9.65
Financials (FY)
Revenue (FY)
$25.12B+11.16%
Net Income (FY)
$3.25B+8.45%
Profit marginThe share of revenue left as profit after all costs and taxes.
14.43%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
383.57M
1-Year Return
−20.77%
Dividend and dates
Dividend
$3.52+1.16%
Ex-Dividend Date
September 30, 2026
Earnings Date
October 29, 2026
Avg Volume
2.65M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, SYK closed at $297.60, −20.77% over 1 year.

Stryker Corporation (SYK) has a market capitalization of $114.15B.

In fiscal 2025, SYK reported revenue of $25.12B.

SYK Stock Return by Calendar Year

Stryker Corporation (SYK) 10-year return: what $10,000 became

1 year
$10,000 $7,923
−20.77%
5 years
$10,000 $11,348
+13.48%
10 years
$10,000 $29,228
+192.28%

If you had invested $10,000 in Stryker Corporation (SYK) 10 years ago, at the close on October 21, 2016, it would have been worth $29,228 at the close on October 21, 2026: +192.28% in total, +11.32% a year, with dividends reinvested. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−14.60%
2025−1.48%
2024+21.34%
2023+23.80%
2022−7.42%
2021+10.22%
2020+18.17%
2019+35.33%
2018+2.43%
2017+30.84%
2016 (partial year)+4.72%

As of October 21, 2026.

SYK Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$25.12B$3.25B12.9%
2024$22.60B$2.99B13.2%
2023$20.50B$3.17B15.4%
2022$18.45B$2.36B12.8%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$25.12B$16.07B$5.06B$3.25B12.9%
2024$22.60B$14.44B$4.67B$2.99B13.2%
2023$20.50B$13.06B$3.92B$3.17B15.4%
2022$18.45B$11.58B$3.11B$2.36B12.8%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

SYK Dividend History

$3.40+4.9% vs 2024

Dividends per share, 2025 · 4 payments

YearDividends per sharePaymentsChange
2026*$2.643—
2025$3.404+4.9%
2024$3.244+6.2%
2023$3.054+7.6%
YearDividends per sharePaymentsChange
2026 (partial year)$2.643—
2025$3.404+4.9%
2024$3.244+6.2%
2023$3.054+7.6%
2022$2.844+9.7%
2021$2.594+9.8%
2020$2.364+10.3%
2019$2.144+10.6%
2018$1.934+10.6%
2017$1.754+310.6%
2016$0.431—

Most recent payment: $0.88 per share, ex-dividend September 30, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

SYK Valuation vs Medical Devices Median

Median of 145 stocks
MetricSYKMedical Devices medianvs median
P/E30.8427.0814% above
P/S ratio4.422.5375% above
Profit margin14.43%−14.78%29.2 pts above

Medians across 145 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Stryker Corporation (SYK) at $114.15B. It is classified in the Medical Devices industry, within the Healthcare sector. The company reports 56,000 employees.

Over the past 52 weeks the price has ranged from $267.00 to $392.55. SYK last closed at $297.60 on October 21, 2026. That is −$6.80 (−2.23%) against the previous close. The latest close sits 11.46% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $25.12B. That is +11.16% against the prior fiscal year, when revenue was $22.60B. The same year closed with net income of $3.25B. That is +8.45% against the prior fiscal year. The reported profit margin is 14.43%. That is 29.2 percentage points above the Medical Devices median of −14.78%. Trailing earnings per share are 9.65.

Across the 4 fiscal years on file, revenue moves from $18.45B in 2022 to $25.12B in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

On trailing earnings, the shares are priced at 30.84 times earnings. That is 13.88% above the Medical Devices median of 27.08. On forward earnings the ratio is 17.86. The PEG ratio, which sets the P/E against expected earnings growth, reads 1.42. The price-to-sales ratio is 4.42. On price-to-sales that is 74.65% above the Medical Devices median of 2.53. 145 Medical Devices companies report these metrics, and the medians quoted come from that group.

The trailing one-year total return is −20.77%. Across 10 years the annualized return works out at +11.32%. The reported beta is 0.78. Daily returns over the trailing 10 years annualize to a volatility of 27.08%.

Growth & Income

Shareholders receive a dividend, yielding 1.16% on the latest price. At the indicated rate that is $3.52 a share a year. The ex-dividend date on file is September 30, 2026. Dividends are recorded for 11 calendar years; 2026 shows 3 payments totalling $2.64 a share. The year before, 2025, totalled $3.40 a share.

The strongest complete calendar year on file is 2019 at +35.33%; the weakest is 2022 at −7.42%. Of the 9 complete calendar years on file, 7 finished higher. So far in 2026 the total return is −14.60%.

Peer Comparison

Stryker Corporation (SYK) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Stryker Corporation SYK $114.15B 30.8
Abbott Laboratories ABT $173.92B 32.4
Medtronic plc. MDT $119.00B 22.9
Boston Scientific Corporation BSX $64.33B 18.0

The Medical Devices industry average P/E ratio is 27.1x. Stryker Corporation trades at a P/E of 30.8.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$173.92B

 MDT

Medtronic plc.

$119.00B

 BSX

Boston Scientific Corporation

$64.33B

 EW

Edwards Lifesciences Corporation

$50.95B

 GEHC

GE HealthCare Technologies Inc.

$31.17B

 DXCM

DexCom, Inc.

$30.29B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About Stryker Corporation

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Visit website →